Dosage and usage of Ivosidenib

Ivosidenib (Ivosidenib) is a targeted therapy drug used to treat acute myeloid leukemia (AML). Its dosage and usage are usually determined based on the patient's specific condition and individual differences. The following is a detailed introduction to the dosage and usage of Avonib:

1. Medication Guide: Before patients start using ivonib, they usually need to be tested for IDH1 gene mutations to ensure that their genotype meets the indications of the drug. The purpose of this step is to determine whether the patient belongs to the subtype with IDH1 gene mutation, because ivonib mainly targets patients with this specific subtype of AML.

2. Initial treatment: The initial treatment plan for ivonib is usually designed by the doctor based on the patient's specific situation. In general, the recommended initial dose is 500 mg orally daily for continuous use. Patients should take their medications exactly as directed, under the supervision of a physician, and follow the prescribed schedule.

3. Treatment monitoring and adjustment: During the treatment process, the doctor will regularly monitor the patient's condition and the effectiveness of the drug. This may include blood tests, bone marrow aspiration and other tests to evaluate the response of the AML cells. Based on monitoring results, doctors may sometimes need to adjust the dose of ivonib to achieve the best therapeutic effect.

4. Duration of treatment: Avosidenib is usually a long-term treatment and patients may need to continue using it under the supervision of a doctor. The duration of treatment will vary based on the patient's condition, the effectiveness of the drug, and possible side effects. Doctors will maintain close contact with patients during the treatment process to ensure that the use of ivonib is safe and effective.

5. Drug interactions: When using ivonib, patients need to inform their doctor about other drugs they are taking to avoid possible drug interactions. In particular, some drugs that may affect drug metabolism, such as strong CYP3A4 inhibitors, may need to be adjusted.

6. Medication for Special Populations: For special populations, such as elderly patients, patients with hepatic insufficiency, or patients with renal insufficiency, doctors may need to adjust the dose of ivonib. Therefore, before starting treatment, doctors will fully assess the patient's general condition to ensure the safety of the medication.

7. Side effects management: When using ivonib, patients may experience some mild discomfort, such as nausea, vomiting, fatigue, etc. Doctors usually advise patients to take appropriate medications or adjust their medication schedule to alleviate these discomforts. In addition, regular electrocardiogram monitoring and liver function monitoring are also routine safety monitoring methods.

8. Discontinuation considerations: In some cases, such as serious adverse reactions or disease progression, doctors may consider suspending or discontinuing the use of ivonib. Such decisions typically require consideration of the patient's condition, response to treatment, and potential risks.

The dosage and usage of ivonib is a complex process that requires doctors to make personalized designs based on the patient's condition and individual differences. Patients should closely follow the doctor's advice when using ivonib, take medication in accordance with the prescribed medication guidelines, and participate in regular treatment monitoring to ensure the safety and effectiveness of the treatment.

Avosidenib is already on the market in China, but it has not yet been included in medical insurance. The price of Avosidenib on the domestic market is very high, reaching tens of thousands of yuan. For specific prices, please consult the local hospital pharmacy. The price of the American original drug of Ivonib abroad is as high as hundreds of thousands. Currently, there are generic drugs of Ivonib on the market, mainly Laos generic drugs, which cost about 10,000 yuan, which is much cheaper in comparison, and the ingredients of the original drug and the generic drug are basically the same.